OTC drugs sale rise @10%: Assocham

OTC drugs sale rise @10%: Assocham
Comment E-mail Print Share
First Published: Thu, May 08 2008. 02 47 PM IST
Updated: Thu, May 08 2008. 02 47 PM IST
New Delhi: Higher medical professional charges coupled with excessive desire for self-medication and increasing faith in traditional ayurvedic medicines, India’s over the counter drug sale has grown around 10% in the last two years, leaving USA and China way behind, with their OTC drug sale estimated at 4% to 5% respectively.
The above findings are based on a study that tracked the latest OTC drug sale patterns, highlighting that the share of sale of OTC traditional drugs in India has gone up to 30% as against cold and cough medicines, 12% vitamins and 7% analgesics.
Key Findings
* Maximum number of OTC drugs sold by qualified chemists and pharmacists are from branded companies like Pfizer Inc., share of which is estimated at about 8%, followed by Sanofi-Aventis 7% and Johnson & Johnson 5.5%
* Main reasons as to why OTC drugs, which fall under the category of Scheduled H of Drugs and Cosmetics Act, 1940 and can be sold without prescriptions from qualified doctors are increasing since the common man avoids consulting private medical practitioners owing to high professional fees
* People’s faith in reviving traditional ayurvedic medicines is going up, with druggists, pharmacists and special retailers including super markets and hyper markets stocking up the same
* Advertisements on OTC drugs often appear in electronic and print media since these are legally permitted, influencing a large number of people to go in for them
Comment E-mail Print Share
First Published: Thu, May 08 2008. 02 47 PM IST